Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 124   

Articles published

GSK 1,448.29 -23.21 (-1.58%)
price chart
Is GlaxoSmithKline plc about to bomb?
In recent years, GlaxoSmithKline (LSE: GSK) has been a major disappointment for its investors. Its share price has slumped by 12% in the last three years as bribery allegations, the loss of patents on key drugs, and a lack of sufficient replacements ...
GlaxoSmithKline plc 13.5% Potential Upside Indicated by Barclays Capital
GlaxoSmithKline plc using EPIC/TICKER code LON:GSK had its stock rating noted as 'Reiterates' with the recommendation being set at 'OVERWEIGHT' today by analysts at Barclays Capital.
GlaxoSmithKline PLC reiterated as Overweight By Barclays Capital  Risers & Fallers
GlaxoSmithKline PLC (LON:GSK) Overweight Rating Reiterated at Barclays ...  Franklin Independent
The numbers don't lie, GlaxoSmithKline plc is set to beat AstraZeneca plc this ...
GlaxoSmithKline (LSE: GSK) has made a great start to 2016. The company's first-quarter results released at the end of last week, showed that Glaxo is on course to increase earnings by 10% to 12% this year, which is slightly ahead of market expectations.
Two Stocks within Analysts Review: AbbVie Inc. (NYSE:ABBV) , GlaxoSmithKline ...
GlaxoSmithKline PLC (NYSE:GSK) moved in red zone with decline of -0.15 points or -0.35% to $43.14. The company has a market worth of $104.40B.
GlaxoSmithKline PLC (NYSE:GSK) Yearly EPS Target At $2.53  Enterprise Leader
Stock's Earnings Activity: GlaxoSmithKline plc (ADR) (NYSE:GSK)  News Oracle
Have income investors forgotten just how good GlaxoSmithKline plc and Vodafone ...
Nobody expects pharmaceuticals giant GlaxoSmithKline (LSE: GSK) to be a share price growth machine, but recent performance has still been patchy.
Strong sales growth and reduced costs boost GlaxoSmithKline plc's results
Shares in GlaxoSmithKline (LSE: GSK) were given a boost today with the healthcare company releasing a positive set of results for the first quarter of the year.
GlaxoSmithKline First-Quarter Earnings Signal Strong Profit Growth this Year  Bidness ETC
GlaxoSmithKline (GSK) Q1 Earnings Lag, Revenues Up Y/Y  Zacks.com
Pharma fight! Should you buy GlaxoSmithKline plc, Smith & Nephew plc or ...
However, GlaxoSmithKline has thrown the kitchen sink at replacing these blockbuster brands to drive group sales higher again.
Is It Time To Buy GlaxoSmithKline plc, Intertek Group plc & Weir Group plc?
Today I'll be taking a closer look at pharmaceutical giant GlaxoSmithKline (LSE: GSK), product testing specialist Intertek (LSE: ITRK) and engineering firm Weir Group (LSE: WEIR).
The Week ahead: GlaxoSmithKline plc, BP plc and Standard Chartered plc
Kicking off with GlaxoSmithKline (LSE: GSK), it's the only company to outpace the index over the last 12-month period.
What This Top Dividend Trust Is Holding Now: GlaxoSmithKline plc, BP plc And ...
Picking great dividend shares has helped Temple Bar Investment Trust (LSE: TMPL) outperform the FTSE All-Share Index over the past three, five and 10 years, and the trust declared a 32nd consecutive annual dividend increase on its results in February.